CA2551474A1 - Medical lipolysis of fat accumulations - Google Patents
Medical lipolysis of fat accumulations Download PDFInfo
- Publication number
- CA2551474A1 CA2551474A1 CA002551474A CA2551474A CA2551474A1 CA 2551474 A1 CA2551474 A1 CA 2551474A1 CA 002551474 A CA002551474 A CA 002551474A CA 2551474 A CA2551474 A CA 2551474A CA 2551474 A1 CA2551474 A1 CA 2551474A1
- Authority
- CA
- Canada
- Prior art keywords
- weight
- fat
- acid
- phospholipid
- employed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Child & Adolescent Psychology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10361067.7 | 2003-12-22 | ||
DE10361067A DE10361067A1 (de) | 2003-12-22 | 2003-12-22 | Medikamentöse Lipolyse von Fettansammlungen |
PCT/EP2004/014134 WO2005063169A2 (de) | 2003-12-22 | 2004-12-11 | Medikamentöse lipolyse von fettansammlungen |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2551474A1 true CA2551474A1 (en) | 2005-07-14 |
Family
ID=34673059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002551474A Abandoned CA2551474A1 (en) | 2003-12-22 | 2004-12-11 | Medical lipolysis of fat accumulations |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1699490A2 (pt) |
JP (1) | JP2007515439A (pt) |
KR (1) | KR20060121238A (pt) |
CN (1) | CN1897974A (pt) |
AU (1) | AU2004308072A1 (pt) |
BR (1) | BRPI0417932A (pt) |
CA (1) | CA2551474A1 (pt) |
DE (1) | DE10361067A1 (pt) |
IL (1) | IL176026A0 (pt) |
MX (1) | MXPA06006645A (pt) |
WO (1) | WO2005063169A2 (pt) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8298556B2 (en) | 2004-05-19 | 2012-10-30 | The Regents Of The University Of California | Methods and related compositions for the non-surgical removal of fat |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
US8846066B2 (en) | 2004-05-19 | 2014-09-30 | The Regents Of The University Of California | Methods and related compositions for reduction of fat and skin tightening |
US9186364B2 (en) | 2009-03-03 | 2015-11-17 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
US11298314B2 (en) | 2017-04-21 | 2022-04-12 | Ami Pharm Co., Ltd. | Injectable composition for localized fat reduction without pain, edema, and side effects, and method for preparing same |
US11344561B2 (en) | 2011-02-18 | 2022-05-31 | Allergan Sales, Llc | Treatment of submental fat |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
PT1845938T (pt) * | 2005-02-08 | 2019-07-11 | Univ California | Métodos e composições relacionadas para redução da gordura e para refirmar a pele |
DE102007015701A1 (de) | 2007-03-19 | 2008-09-25 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Neue pharmazeutische Zusammensetzungen für die Lipolyse und Verfahren zu deren Herstellung |
FR2937554B1 (fr) * | 2008-10-27 | 2010-11-12 | Yves Crassas | Solutions salines aqueuses pour la destruction de tissus graisseux |
JP6006940B2 (ja) * | 2009-03-02 | 2016-10-12 | ヘクセル,ドリス | 医学的美容脂肪萎縮方法 |
SG178559A1 (en) | 2009-08-25 | 2012-03-29 | Medrx Co Ltd | Transdermal composition of phosphatidylcholine and method for producing same |
DE102010028365A1 (de) | 2010-04-29 | 2011-11-03 | Lichtblick Gmbh | Verwendung einer Phospholipid enthaltenden Zusammensetzung zur Entfernung von subkutanen Fettansammlungen |
CN108619089A (zh) * | 2011-08-23 | 2018-10-09 | 凯瑟拉生物制药有限公司 | 脱氧胆酸和其盐的制剂 |
RU2016141131A (ru) * | 2014-03-21 | 2018-04-23 | Нестек С.А. | Введение витамина b2 матери для профилактики повышенной тучности, избыточного веса или ожирения у потомства |
KR102093872B1 (ko) * | 2017-07-03 | 2020-03-27 | 진호성 | 지방제거용 주사제 조성물 및 이의 제조방법 |
JP6356329B2 (ja) * | 2017-09-27 | 2018-07-11 | キテラ バイオファーマシューティカルズ,インコーポレイテッド | デオキシコール酸およびその塩類の製剤 |
KR101865562B1 (ko) * | 2017-11-03 | 2018-06-08 | 주식회사 펜믹스 | 포스포콜린 유도체를 포함하는 지방분해 조성물 |
KR20190095833A (ko) * | 2018-02-07 | 2019-08-16 | 이기택 | 고통 및 부작용이 없는 국소지방 감소용 포스파티딜콜린 비포함 주사제 조성물 |
CN110302082A (zh) * | 2018-03-27 | 2019-10-08 | 上海同柏生物科技有限公司 | 用于减少身体脂肪沉积的技术及组合物制剂与应用 |
CN109674696A (zh) * | 2018-03-27 | 2019-04-26 | 上海同柏生物科技有限公司 | 一种用于腹部脂肪降解技术及其制剂与应用 |
EP4159240A1 (en) | 2020-06-01 | 2023-04-05 | Cosmed Pharmaceutical Co., Ltd. | Beauty microneedle array |
JP2022020578A (ja) * | 2020-07-20 | 2022-02-01 | コスメディ製薬株式会社 | 美容用外用剤及び化粧料 |
KR102513115B1 (ko) * | 2020-12-18 | 2023-03-22 | 주식회사 레시텍 | 리토콜릭산을 포함하는 국소지방 감소용 조성물 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10349979B4 (de) * | 2003-10-24 | 2006-05-18 | Sanofi-Aventis Deutschland Gmbh | Medikamentöse gezielte lokale Lipolyse |
-
2003
- 2003-12-22 DE DE10361067A patent/DE10361067A1/de not_active Withdrawn
-
2004
- 2004-12-11 CA CA002551474A patent/CA2551474A1/en not_active Abandoned
- 2004-12-11 BR BRPI0417932-3A patent/BRPI0417932A/pt not_active IP Right Cessation
- 2004-12-11 EP EP04803773A patent/EP1699490A2/de not_active Ceased
- 2004-12-11 AU AU2004308072A patent/AU2004308072A1/en not_active Abandoned
- 2004-12-11 MX MXPA06006645A patent/MXPA06006645A/es unknown
- 2004-12-11 CN CNA2004800386251A patent/CN1897974A/zh active Pending
- 2004-12-11 KR KR1020067012553A patent/KR20060121238A/ko not_active Application Discontinuation
- 2004-12-11 WO PCT/EP2004/014134 patent/WO2005063169A2/de not_active Application Discontinuation
- 2004-12-11 JP JP2006545984A patent/JP2007515439A/ja not_active Abandoned
-
2006
- 2006-05-30 IL IL176026A patent/IL176026A0/en unknown
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8298556B2 (en) | 2004-05-19 | 2012-10-30 | The Regents Of The University Of California | Methods and related compositions for the non-surgical removal of fat |
US10058561B2 (en) | 2004-05-19 | 2018-08-28 | The Regents Of The University Of California | Methods and related compositions for reduction of fat and skin tightening |
US8846066B2 (en) | 2004-05-19 | 2014-09-30 | The Regents Of The University Of California | Methods and related compositions for reduction of fat and skin tightening |
US9186364B2 (en) | 2009-03-03 | 2015-11-17 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
US9724356B2 (en) | 2009-03-03 | 2017-08-08 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
US10071105B2 (en) | 2009-03-03 | 2018-09-11 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
US10500214B2 (en) | 2009-03-03 | 2019-12-10 | Allergan Sales, Llc | Formulations of deoxycholic acid and salts thereof |
US11179404B2 (en) | 2009-03-03 | 2021-11-23 | Allergan Sales, Llc | Formulations of deoxycholic acid and salts thereof |
US11344561B2 (en) | 2011-02-18 | 2022-05-31 | Allergan Sales, Llc | Treatment of submental fat |
US9737549B2 (en) | 2011-04-05 | 2017-08-22 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
US10946030B2 (en) | 2011-04-05 | 2021-03-16 | Allergan Sales, Llc | Formulations of deoxycholic acid and salts thereof |
US11298314B2 (en) | 2017-04-21 | 2022-04-12 | Ami Pharm Co., Ltd. | Injectable composition for localized fat reduction without pain, edema, and side effects, and method for preparing same |
Also Published As
Publication number | Publication date |
---|---|
CN1897974A (zh) | 2007-01-17 |
IL176026A0 (en) | 2006-10-05 |
EP1699490A2 (de) | 2006-09-13 |
WO2005063169A3 (de) | 2006-05-04 |
WO2005063169A2 (de) | 2005-07-14 |
DE10361067A1 (de) | 2005-07-14 |
KR20060121238A (ko) | 2006-11-28 |
MXPA06006645A (es) | 2006-08-31 |
BRPI0417932A (pt) | 2007-04-17 |
JP2007515439A (ja) | 2007-06-14 |
AU2004308072A1 (en) | 2005-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100004216A1 (en) | Medicinal lipolysis of accumulation of fat | |
CA2551474A1 (en) | Medical lipolysis of fat accumulations | |
US20120329765A1 (en) | Medicinal targeted local lipolysis | |
KR100752990B1 (ko) | 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물 | |
CA2872279C (en) | Topical lipolysis compositions and methods | |
KR101791277B1 (ko) | 피부과학 및 미용학적 조성물 | |
US20090137663A1 (en) | Therapeutic micro nutrient composition for drug delivery | |
EP1684722B1 (de) | Medikamentöse gezielte lokale lipolyse | |
RU2549966C2 (ru) | Применение фосфолипид-содержащей композиции для удаления подкожных скоплений жира посредством подкожного липолиза | |
WO2013151341A1 (en) | Injectable composition comprising phosphatidylcholine and method for preparing thereof | |
JP2004002446A (ja) | 経鼻、経舌下、経直腸及び経皮投与のためのnadh及びnadph治療剤 | |
US20140113883A1 (en) | Therapeutic micro nutrient composition for lipolysis and sclerosis | |
KR101775266B1 (ko) | 신규한 트라넥사민산 담지 액정나노입자 및 그의 제조방법 | |
US9173940B1 (en) | Mixture of betamethasone and tranilast with a transdermal gel for scar treatment | |
US20090221528A1 (en) | Therapeutic micro nutrient composition for lipolysis and sclerosis | |
KR102145376B1 (ko) | 콜린알포세레이트를 포함하는 국소지방 제거용 주사제 조성물 | |
US20220047499A1 (en) | Topical Lipolysis Composition and Methods | |
TWI815349B (zh) | 山竹果殼萃取物用於製備促進糖尿病傷口癒合的藥物的用途 | |
RU2483748C2 (ru) | Фармацевтическая композиция, содержащая инсулин и липосомы, для местного применения в виде пластыря | |
CN116763832A (zh) | 山竹果壳萃取物用于制备促进糖尿病伤口愈合的药物的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |